Successful treatment with photodynamic therapy in a patient with nasal mucocutaneous leishmaniasis undergoing treatment with TNFα inhibitor
- PMID: 33331279
- PMCID: PMC7880660
- DOI: 10.1684/ejd.2020.3921
Successful treatment with photodynamic therapy in a patient with nasal mucocutaneous leishmaniasis undergoing treatment with TNFα inhibitor
References
-
- Morton CA, Szeimies R-M, Basset-Séguin N, et al. European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 2: emerging indications — field cancerization, photorejuvenation and inflammatory/infective dermatoses. J Eur Acad Dermatol Venereol. 2020;34:17–29. doi: 10.1111/jdv.16044. - DOI - PubMed
-
- Pérez-Laguna V, García-Malinis AJ, Aspiroz C, Rezusta A, Gilaberte Y. Antimicrobial effects of photodynamic therapy. G Ital Dermatol E Venereol. 2018;153:833–46. - PubMed
-
- Silva MLF, Alves PM, Souza DM, et al. Analysis of macrophage activation markers in an experimental model of cutaneous leishmaniasis treated with photodynamic therapy mediated by 5-aminolevulinic acid. Photobiomodulation Photomed Laser Surg. 2019;37:298–304. doi: 10.1089/photob.2018.4574. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
